NEUMANN CLARKE (General Counsel and Secretary) received a stock award from BIORA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/17/2023ACC: 0000899243-23-009036
Officer· General Counsel and Secretary
Since Jun 2020
+68.95K
Net shares
Net buyer
$27.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
79.63K acquired · 10.68K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+57.95K
Price / share
—
Trade value
—
% of position
268.1%
3/15/2023
21.62K→79.57K
Common Stock
Direct
Shares
+21.68K
Price / share
—
Trade value
—
% of position
27.3%
3/15/2023
79.57K→101.25K
Common Stock
Direct
Shares
−10.68K
Price / share
$2.56
Trade value
$27.35K
% of position
10.6%
3/15/2023
101.25K→90.57K
Total
Net shares
+68.95K
Net value
-$27.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2023 | A · Award | +57.95K | — | — | 268.1% | 21.62K | 79.57K |
| Common Stock Direct | 3/15/2023 | A · Award | +21.68K | — | — | 27.3% | 79.57K | 101.25K |
| Common Stock Direct | 3/15/2023 | F · Tax Withholding | −10.68K | $2.56 | $27.35K | 10.6% | 101.25K | 90.57K |
| Total | +68.95K | -$27.35K | ||||||
Derivative Transactions0
No derivative transactions reported